Use of new technologies for monitoring and treating diabetes in pregnancy.
During the last century, there were two breakthroughs in diabetes management and monitoring that changed the course of treatment: the discovery of insulin and the progress in the understanding of glucose monitoring. As technology evolved, glucose monitoring and insulin administration can now be achieved in a continuous fashion. In this review, the authors focus on the utility of new technologies in the management and monitoring of diabetes in pregnancy.
Yogev
Yariv
Y
Perinatal Division, Helen Schneider Hospital for Women, Rabin Medical Center, Petach Tikva, 49100, Tel Aviv University, Israel. yarivyogev@hotmail.com
Hod
Moshe
M
D001786:Blood Glucose / Q000032:analysis*; D015190:Blood Glucose Self-Monitoring; D016640:Diabetes, Gestational / Q000628:therapy*; D005260:Female; D019270:Fructosamine / Q000097:blood; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage; D007328:Insulin / Q000008:administration & dosage; D007332:Insulin Infusion Systems; D018670:Monitoring, Ambulatory; D019397:Pancreas, Artificial; D019518:Postprandial Period; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000628:therapy*
D001786:Blood Glucose; D019270:Fructosamine; D006442:Glycated Hemoglobin; D007004:Hypoglycemic Agents; D007328:Insulin